Graduate student Lina Colucci speaks with Elisabeth Pain of Science about combining her passion for dance with her work as an engineer. Colucci explains that she is using her knowledge of “biomechanics to change the materials and structural design” of ballet shoes.
A team of MIT researchers has found that the brain’s cortical thickness differs between low-income and high-income teenagers, reports Lyndsey Layton for The Washington Post. “The thing that really stands out is how powerful the economic influences are on something as fundamental as brain structure,” said Prof. John Gabrieli.
Kevin McSpadden of Time reports on Panoply, a social networking platform developed by researchers from MIT and Northwestern that is aimed at helping users deal with anxiety and depression. Panoply teaches “users a therapeutic tool called cognitive reappraisal, which tries to get people to look at a problematic situation from different perspectives.”
Nidhi Subbaraman of BetaBoston writes about a new online networking tool developed by MIT researchers that has been found to be effective in helping people cope with anxiety and depression. Researchers found that those who used the tool were “writing about their issues much more."
Researchers from MIT and Northwestern have developed an online networking tool aimed at aiding people with anxiety and depression, reports Katie Collins for Wired. The tool, “allows people to build online support communities and practice therapeutic techniques among one another.”
MIT researchers have developed a test for Ebola and other fevers using gold nanoparticle sensors that quickly identify the pathegon, writes Andrea Timpano for Boston Magazine. “It is important to recognize that the United States needs to have strategies for surveillance that will identify dangerous viruses,” says Professor Lee Gehrke.
“A promising new diagnostic test from MIT looks like it could be a game changer for rapidly diagnosing several important infectious diseases within minutes,” writes Judy Stone for Forbes. The paper test developed by MIT researchers can diagnose Ebola, yellow fever and dengue fever.
MIT researchers have developed a new silver nanoparticle-based paper test that can quickly detect dengue, yellow fever and Ebola, reports Vicki Davison for Scientific American. In addition to the paper test, the researchers are also working on developing a mobile application to ease diagnosis.
Michelle Roberts reports for BBC News on a new, “smart insulin” being developed by MIT researchers that switches on when blood sugar rises. The engineered insulin could make it easier for those suffering from diabetes to manage the disease, Roberts explains.
MIT engineers are developing a paper test that can identify Ebola, writes BetaBoston reporter Nidhi Subbaraman. Prof. Lee Gehrke’s goal is to develop a “cheap, disposable front-line detector for this disease that many people can get their hands on — and fast,” Subbaraman reports.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”
Atlantic reporter Cari Romm reports on how MIT researchers have devised an alternative drug-delivery method: A pill covered with tiny needles. The researchers plan to improve their current design by creating a “fully biodegradable version of the pill.”
WCVB reports that researchers from MIT and Massachusetts General Hospital have developed a pill coated with tiny needles that can deliver drugs directly into the digestive tract. The pill was found to deliver insulin more efficiently than current methods, WCVB reports.
“Researchers at the Massachusetts Institute of Technology have developed a pill-like capsule that injects medication into the stomach lining after being swallowed,” reports Sky News. The new capsule could allow for oral delivery of drugs that currently must be injected.
MIT scientists have developed a pill coated in tiny needles that allows medicine to be absorbed through the lining of the stomach, writes Brooks Hays of UPI. Initial trials showed that the pill delivered insulin more efficiently than an injection.